Comments on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers"
- PMID: 37231566
- DOI: 10.1002/jmv.28822
Comments on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers"
Comment in
-
Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".J Med Virol. 2023 May;95(5):e28820. doi: 10.1002/jmv.28820. J Med Virol. 2023. PMID: 37226974 No abstract available.
Comment on
-
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9. J Med Virol. 2022. PMID: 36029103 Free PMC article.
Similar articles
-
Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".J Med Virol. 2023 May;95(5):e28820. doi: 10.1002/jmv.28820. J Med Virol. 2023. PMID: 37226974 No abstract available.
-
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9. J Med Virol. 2022. PMID: 36029103 Free PMC article.
-
In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.J Med Virol. 2023 Jan;95(1):e28213. doi: 10.1002/jmv.28213. Epub 2022 Oct 17. J Med Virol. 2023. PMID: 36224626 Free PMC article. No abstract available.
-
Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.J Med Virol. 2023 Jan;95(1):e28313. doi: 10.1002/jmv.28313. Epub 2022 Nov 21. J Med Virol. 2023. PMID: 36380449 No abstract available.
-
Vaccination options for pregnant women during the Omicron period.J Reprod Immunol. 2023 Mar;156:103798. doi: 10.1016/j.jri.2023.103798. Epub 2023 Jan 6. J Reprod Immunol. 2023. PMID: 36640675 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous